{
  "chat_config": {
    "chat_model": "Qwen/Qwen3-8B",
    "lora": false,
    "chat_model_type": "chat",
    "chat_model_inference_engine": "openai",
    "chat_system_message": "You are a helpful assistant.",
    "chat_endpoint": "https://api.siliconflow.cn/v1/chat/completions",
    "chat_parameters": {
      "temperature": 0.6,
      "max_tokens": 1024
    },
    "chat_request_sleep": {
      "sleep_time": 2,
      "sleep_every_count": 10
    },
    "chat_max_new_token": 1000,
    "chat_request_timeout": 1000,
    "chat_vllm_endpoint": "http://0.0.0.0:8000"
  },
  "emb_config": {
    "emb_model_name": "Qwen/Qwen3-Embedding-4B",
    "request_endpoint": "https://api.siliconflow.cn/v1/embeddings",
    "emb_size": 2560,
    "embedding_timeout": 600
  },
  "env_config": {
    "trading_symbols": [
      "JNJ"
    ],
    "warmup_start_time": "2020-07-02",
    "warmup_end_time": "2020-07-10",
    "test_start_time": "2020-10-01",
    "test_end_time": "2021-05-06",
    "momentum_window_size": 3,
    "env_data_path": {
      "JNJ": "data/jnj.json"
    }
  },
  "portfolio_config": {
    "trading_symbols": [
      "JNJ"
    ],
    "type": "single-asset",
    "look_back_window_size": 3
  },
  "agent_config": {
    "agent_name": "agent",
    "trading_symbols": [
      "JNJ"
    ],
    "character_string": {
      "JNJ": "You accumulate a lot of information about Johnson & Johnson (JNJ) in the following sectors so you are especially good at trading them: (1) Pharmaceuticals Sector: This is the largest segment of Johnson & Johnson, involving the research, development, and sale of pharmaceutical products across various therapeutic areas such as immunology, oncology, neurology, and infectious diseases. (2) Medical Devices Sector: JNJ is a significant player in the medical devices sector, providing a wide range of products used in orthopedics, surgery, cardiovascular, diabetes care, and other fields. (3) Consumer Health Sector: This sector includes a broad array of over-the-counter (OTC) products, skin care products, and baby care products, among other consumer health items. You are an investment expert of Johnson & Johnson (JNJ). You learned the following knowledge about Johnson & Johnson (JNJ) based on your professional experience. Johnson & Johnson (JNJ) demonstrated robust financial performance in 2019, generating revenues of $82.1 billion, up 0.6% from the previous year, driven by strong sales in its pharmaceuticals and medical devices segments. The company's net earnings for the year stood at $15.1 billion, reflecting a solid operational performance and strategic management of its diversified healthcare portfolio. JNJ's stock performed well in 2019, buoyed by consistent earnings growth and a reputation for stability in the healthcare sector. In 2020, JNJ faced unprecedented challenges due to the COVID-19 pandemic, impacting its medical devices segment due to reduced elective surgeries. However, its pharmaceuticals and consumer health divisions saw increased demand, particularly for products related to immune health and hygiene. By the end of the third quarter of 2020, JNJ's stock had shown resilience, recovering from a dip in March, driven by positive news regarding its progress on a COVID-19 vaccine candidate and stable financial performance despite global economic uncertainties. At the beginning of the fourth quarter of 2020, professional analysts were optimistic about Johnson & Johnson (JNJ) for the rest of the year and into 2021. They expected continued resilience in JNJ's pharmaceutical and consumer health segments, which could offset challenges faced by the medical devices division due to the pandemic. For 2021, analysts were particularly positive about the potential approval and distribution of JNJ’s COVID-19 vaccine, which could significantly boost the company’s profile and financial performance, alongside a recovery in elective medical procedures as global conditions improve."
    },
    "top_k": 5,
    "memory_db_config": {
      "memory_db_endpoint": "http://localhost:6333",
      "memory_importance_upper_bound": 100.0,
      "memory_importance_score_update_step": 18.0,
      "trading_symbols": [
        "JNJ"
      ],
      "short": {
        "db_name": "short",
        "importance_init_val": 50.0,
        "decay_recency_factor": 3.0,
        "decay_importance_factor": 0.92,
        "clean_up_recency_threshold": 0.05,
        "clean_up_importance_threshold": 5.0,
        "jump_upper_threshold": 55.0
      },
      "mid": {
        "db_name": "mid",
        "importance_init_val": 60.0,
        "decay_recency_factor": 90.0,
        "decay_importance_factor": 0.96,
        "clean_up_recency_threshold": 0.05,
        "clean_up_importance_threshold": 5.0,
        "jump_lower_threshold": 55.0,
        "jump_upper_threshold": 85.0
      },
      "long": {
        "db_name": "long",
        "importance_init_val": 90.0,
        "decay_recency_factor": 365.0,
        "decay_importance_factor": 0.96,
        "clean_up_recency_threshold": 0.05,
        "clean_up_importance_threshold": 5.0,
        "jump_lower_threshold": 85.0
      },
      "reflection": {
        "db_name": "reflection",
        "importance_init_val": 80.0,
        "decay_recency_factor": 365.0,
        "decay_importance_factor": 0.98,
        "clean_up_recency_threshold": 0.05,
        "clean_up_importance_threshold": 5.0,
        "similarity_threshold": 0.95
      }
    }
  },
  "meta_config": {
    "run_name": "exp",
    "momentum_window_size": 3,
    "warmup_checkpoint_save_path": "results/exp/qwen3-8b-siliconflow/JNJ/warmup_checkpoint",
    "warmup_output_save_path": "results/exp/qwen3-8b-siliconflow/JNJ/warmup_output",
    "test_checkpoint_save_path": "results/exp/qwen3-8b-siliconflow/JNJ/test_checkpoint",
    "test_output_save_path": "results/exp/qwen3-8b-siliconflow/JNJ/test_output",
    "result_save_path": "results/exp/qwen3-8b-siliconflow/JNJ/final_result",
    "log_save_path": "results/exp/qwen3-8b-siliconflow/JNJ/log"
  }
}
